Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Study to Assess Safety, Tolerability, PK and PD of MRT-6160 in Healthy Subjects

NCT06597799 is registered in ClinicalTrials.gov with Monte Rosa Therapeutics, Inc as lead sponsor.

NCT NCT06597799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Study to Assess Safety, Tolerability, PK and PD of MRT-6160 in Healthy Subjects
Lead sponsor
Monte Rosa Therapeutics, Inc
Phase
Phase 1
Overall status
Completed
Start date
August 7, 2024
Completion date
April 10, 2025
Enrollment
108 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers